Major Pharmaceuticals: Levothyroxine Sodium Tablets, Usp, 88 Mcg (0.088 Mg), 100 Tablets (10 X 10 Unit Dose Blisters) Per Carton

Levothyroxine Sodium Tablets Recall Summary Major Pharmaceuticals is recalling 88 mcg levothyroxine sodium tablets (NDC 0904-6952-61) distributed nationwide because the medication is subpotent, meaning it contains less active ingredient than it should. This thyroid medication was distributed across all U.S. states and the District of Columbia. People who filled prescriptions for this specific product and dosage may have received ineffective medication.

Recalling firm

Major Pharmaceuticals

Product

Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6952-61

Reason

Subpotent Drug

Classification

Class II

Category

drug recall

Country

United States

Agency

U.S. Food and Drug Administration

Recall date

2026-07-13

Status

Ongoing

Areas affected

AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...

Distribution

Nationwide in the USA.

Official recall notice from U.S. Food and Drug Administration

Recall details on Nibble Recalls: https://trynibble.app/recalls/5bffdc26-fecf-413f-92d5-338cd09367f3